U.S. Stem Cell, Inc.【USRM】
| Dec 31,
2011 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 |
|---|
| Cash and cash equivalents | 36,828 | 58,372 | 270,720 | 986,799 | 1 | - | 39,393 | 5,133 |
|---|
| Accounts receivable, net of allowance of $75,000 | 3,495 | 35,032 | 16,025 | 42,959 | 18,035 | - | 1,213 | 4,332 |
|---|
| Inventories | 63,702 | 17,406 | 42,218 | 70,364 | 93,215 | - | 393 | 980 |
|---|
| Prepaid expenses and other current assets | - | 4,832 | - | 3,128 | 38,128 | - | 10,000 | 57,594 |
|---|
| Total current assets | 153,853 | 115,642 | 328,963 | 1 | 2 | - | 50,999 | 68,039 |
|---|
| Total assets | 268,493 | 229,113 | 427,636 | 2 | 2 | - | 50,999 | 68,039 |
|---|
| Accounts payable | 2 | 2 | 1 | 1 | 1 | - | 1 | 2 |
|---|
| Accrued expenses | 4 | 726,751 | 904,772 | 929,119 | 1 | - | 2 | 3 |
|---|
| Advances - related parties | - | - | - | - | - | - | - | 1 |
|---|
| Contract liabilities, current portion | - | 71,961 | 126,932 | 211,042 | 293,665 | 3,000 | 3,000 | 3,000 |
|---|
| Deposits | 465,286 | 465,286 | 465,286 | 465,286 | 465,286 | - | 465,286 | 465,286 |
|---|
| Notes payable - related parties | - | - | - | - | - | - | - | 4 |
|---|
| Notes payable, current portion, net of debt discount of $10,515 and $10,052, respectively | - | - | - | - | - | - | 3 | 3 |
|---|
| Promissory note payable | - | 608,502 | 680,336 | 1 | 462,330 | - | 1 | 1 |
|---|
| Convertible notes payable, net of debt discount of $37,224 and $0, respectively | - | - | - | - | - | - | 194,411 | 390,776 |
|---|
| Total current liabilities | 12 | 6 | 6 | 6 | 6 | - | 12 | 14 |
|---|
| Contract liabilities | - | - | 71,500 | 68,500 | 65,500 | - | 56,500 | 53,500 |
|---|
| Notes payable, net of debt discount of $11,059 and $21,575, respectively | - | 983,727 | 982,579 | 687,453 | 1 | - | 722,060 | 682,044 |
|---|
| Total long-term liabilities | - | 2 | 2 | 2 | 3 | - | 778,560 | 735,544 |
|---|
| Total liabilities | 12 | 8 | 8 | 9 | 9 | - | 13 | 15 |
|---|
| Commitments and contingencies (See Note 11) | - | - | - | - | - | - | - | - |
|---|
| Preferred stock, par value $0.001; 20,000,000 shares authorized, -0- issued and outstanding | - | 20,000 | 20,000 | - | - | - | - | - |
|---|
| Common stock, par value $0.001; 2,000,000,000 shares authorized, 634,402,623 and 503,525,051 shares issued and outstanding, respectively | 95,625 | 1,814 | 127,013 | 342,113 | 378,077 | - | 503,525 | 634,403 |
|---|
| Additional paid-in capital | 99 | 115 | 116 | 120 | 123 | - | 127 | 127 |
|---|
| Accumulated deficit | - | -122,076,374 | -124,146,760 | -127,628,251 | -129,788,678 | - | -139,801,924 | -142,517,282 |
|---|
| Total stockholders' deficit | -12,010,477 | -7,721,446 | -8,018,644 | -7,100,317 | -6,882,210 | - | -12,766,336 | -14,745,396 |
|---|
| Total liabilities and stockholders' deficit | 268,493 | 229,113 | 427,636 | 2 | 2 | - | 50,999 | 68,039 |
|---|